BONST
GILD icon

Bank of Nova Scotia Trust’s Gilead Sciences GILD Stock Holding History

Bank of Nova Scotia Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-734
Closed -$60K – 227
2017
Q3 		$60K Buy
+734
New +$56.1K 0.01% 230
2016
Q1 		– Sell
-2,398
Closed -$243K – 111
2015
Q4 		$243K Sell
2,398
-1,542
-39% -$160K 0.04% 102
2015
Q3 		$387K Buy
3,940
+690
+21% +$76.6K 0.05% 89
2015
Q2 		$374K Buy
3,250
+500
+18% +$54.6K 0.05% 98
2015
Q1 		$270K Hold
2,750
– – 0.03% 104
2014
Q4 		$259K Buy
2,750
+75
+3% +$7.76K 0.03% 102
2014
Q3 		$285K Hold
2,675
– – 0.03% 103
2014
Q2 		$228K Buy
+2,675
New +$208K 0.02% 111

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Nova Scotia Trust's GILD Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 734 shares — an estimated $60K sold.

Bank of Nova Scotia Trust first reported a position in GILD in Q2 2014 and held it in 8 quarters. The position peaked at $387K in Q3 2015. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Bank of Nova Scotia Trust reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 734 Gilead Sciences shares in Q4 2017, an estimated $60K.
  • Bank of Nova Scotia Trust first reported a position in Gilead Sciences in Q2 2014 and held it in 8 quarters.
  • Bank of Nova Scotia Trust's Gilead Sciences position peaked at $387K in Q3 2015.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.